$783 Million is the total value of Avoro Capital Advisors LLC's 47 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 52.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS INC | $30,033,000 | +108.7% | 815,000 | -18.2% | 3.84% | +32.0% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $19,274,000 | -16.5% | 425,000 | -30.3% | 2.46% | -47.2% |
| Sell | NEURODERM LTD | $15,665,000 | -33.2% | 590,000 | -44.1% | 2.00% | -57.8% | |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $13,465,000 | +30.4% | 1,603,001 | -1.7% | 1.72% | -17.5% |
| AGEN | Sell | AGENUS INC | $12,700,000 | -17.8% | 3,368,828 | -10.2% | 1.62% | -48.0% |
| SRNE | Sell | SORRENTO THERAPEUTICS INC | $4,709,000 | -34.0% | 1,192,130 | -18.1% | 0.60% | -58.2% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $4,199,000 | -51.5% | 456,369 | -45.1% | 0.54% | -69.4% |
| FBIO | Sell | FORTRESS BIOTECH INC | $3,688,000 | +13.8% | 996,663 | -17.0% | 0.47% | -28.1% |
| CRVS | Sell | CORVUS PHARMACEUTICALS INC | $2,528,000 | -18.4% | 121,715 | -43.8% | 0.32% | -48.4% |
| IMMU | Exit | IMMUNOMEDICS INCcall | $0 | – | -300,800 | -100.0% | -0.01% | – |
| AGEN | Exit | AGENUS INCcall | $0 | – | -1,000,000 | -100.0% | -0.01% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -0.08% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCput | $0 | – | -150,000 | -100.0% | -0.12% | – |
| BDSI | Exit | BIODELIVERY SCIENCES INTL INC | $0 | – | -644,176 | -100.0% | -0.23% | – |
| XNCR | Exit | XENCOR INC | $0 | – | -125,000 | -100.0% | -0.66% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB CO. | $0 | – | -285,000 | -100.0% | -3.36% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -170,000 | -100.0% | -4.20% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -541,000 | -100.0% | -4.23% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -1,010,300 | -100.0% | -5.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 36 | Q3 2023 | 17.9% |
| MIRATI THERAPEUTICS INC. | 35 | Q3 2023 | 17.2% |
| BIOMARIN PHARMACEUTICAL INC | 31 | Q3 2023 | 8.0% |
| SAREPTA THERAPUTICS INC | 28 | Q3 2023 | 14.8% |
| ASCENDIS PHARMA | 28 | Q3 2023 | 9.1% |
| ARGENX SE | 26 | Q3 2023 | 9.5% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
| FENNEC PHARMACEUTICALS INC | 25 | Q3 2023 | 0.4% |
| MADRIGAL PHARMACEUTICALS INC | 22 | Q3 2023 | 7.2% |
| XENON PHARMACEUTICALS INC | 22 | Q3 2023 | 3.3% |
View Avoro Capital Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| DICE Therapeutics, Inc. | February 14, 2023 | 2,525,555 | 5.3% |
| IOVANCE BIOTHERAPEUTICS, INC. | February 14, 2023 | 7,020,000 | 4.4% |
| IVERIC bio, Inc. | February 14, 2023 | 6,750,000 | 5.0% |
| Kura Oncology, Inc. | February 14, 2023 | 3,105,000 | 4.5% |
| Aadi Bioscience, Inc. | September 26, 2022 | 2,849,402 | 11.7% |
| ARENA PHARMACEUTICALS INC | February 11, 2022 | 1,235,000 | 2.0% |
| AVADEL PHARMACEUTICALS PLC | February 11, 2022 | 1,670,000 | 2.9% |
| FENNEC PHARMACEUTICALS INC. | February 11, 2022 | 1,200,000 | 4.6% |
| POINT Biopharma Global Inc.Sold out | February 11, 2022 | 0 | 0.0% |
View Avoro Capital Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-04-23 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Avoro Capital Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.